Scott E. Potenta, Ph.D.
Affiliations: | 2009 | Harvard University, Cambridge, MA, United States |
Area:
Cell BiologyGoogle:
"Scott Potenta"Parents
Sign in to add mentor| Raghu Kalluri | grad student | 2009 | Harvard | |
| (Endothelial -to -mesenchymal transition in cancer progression and tissue fibrosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Medici D, Potenta S, Kalluri R. (2011) Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. The Biochemical Journal. 437: 515-20 |
| Zeisberg EM, Potenta SE, Sugimoto H, et al. (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology : Jasn. 19: 2282-7 |
| Potenta S, Zeisberg E, Kalluri R. (2008) The role of endothelial-to-mesenchymal transition in cancer progression. British Journal of Cancer. 99: 1375-9 |
| Xie L, Palmsten K, MacDonald B, et al. (2008) Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Experimental Biology and Medicine (Maywood, N.J.). 233: 155-62 |
| Zeisberg EM, Potenta S, Xie L, et al. (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Research. 67: 10123-8 |